Abstract:BACKGROUND Aldosterone has been implicated in a variety of organ fibroses, but its role and mechanism in liver fibrosis remain unclear. METHODS Rat primary hepatic stellate cells (HSCs) were isolated, cultured, and characterized. HSCs were incubated with aldosterone (10(-6) M) for 4 h, 8 h, 12 h, 24 h, and 48 h, after which TGF-β1 (transforming growth factor beta 1) expression was measured by real-time PCR. Rat HSCs were treated with different concentrations of aldosterone (10(-6) M, 10(-7) M, 10(-8) M, and 10(-9) M), and the expressions of PAI-1 (plasminogen activator inhibitor-1) and TGF-β1 were determined by measuring mRNA and protein. HSCs were incubated in groups containing aldosterone (10(-6) M), spironolactone (10(-5) M), both aldosterone and spironolactone, or neither aldosterone nor spironolactone (control), after which mRNA and protein expression of PAI-1 and TGF-β1 were measured. Collagen I expression was detected by immunohistochemical analysis of supernatants of the aldosterone (10(-6) M), TGF-β1, and aldosterone plus TGF-β1 groups. SMAD expression was detected in rat HSC control, HSC plus aldosterone (10(-6) M), HSC plus TGF-β1, and HSC plus aldosterone plus TGF-β1 groups. RESULTS HSCs were incubated with aldosterone for 4 h, 8 h, 12 h, 24 h, and 48 h after which TGF-β1 expression was measured. We found that TGF-β1 expression increased in a time dependent manner and reached a peak at 24 h. The expression of TGF-β1 in groups treated with aldosterone for 4 h, 8 h, 12 h, and 24 h was significantly different from the control group (P < 0.01). No significant difference was seen in TGF-β1 expression between the groups treated with aldosterone for 24 h and 48 h (P > 0.05). Compared with the control group, TGF-β1 expression was significantly increased after incubation with different concentrations of aldosterone (10(-6) M, 10(-7) M, 10(-8) M, and 10(-9) M) (P < 0.01). There were significant differences in the expression of TGF-β1 between 10(-6) M and 10(-7) M aldosterone treatment groups (P < 0.01). Compared with the control group, the expression of PAI-1 was significantly increased after incubation with different concentrations of aldosterone (10(-6) M, 10(-7) M, 10(-8) M, and 10(-9) M) (P < 0.01). PAI-1 expression was increased in the aldosterone, spironolactone, and aldosterone plus spironolactone groups. The expression of PAI-1 was significantly enhanced in the aldosterone and aldosterone plus spironolactone groups compared with the control group (P < 0.01). There was a marked enhancement of collagen I expression in the aldosterone, TGF-β1, and aldosterone plus TGF-β1 groups (P < 0.05). Collagen I expressions in the aldosterone and TGF-β1 groups were significantly different from the aldosterone plus TGF-β1 group (P < 0.01). Compared with the control group, SMAD expression was markedly elevated in the aldosterone, TGF-β1, and aldosterone plus TGF-β1 groups (P < 0.05). The expression of SMAD was significantly increased in the aldosterone plus TGF-β1 group compared with the aldosterone group (P < 0.01). CONCLUSION This study demonstrated that aldosterone promoted HSC activation and the expression of TGF-β1, PAI-1, and collagen in hepatic fibrosis progression and that spironolactone administration partially reversed the effects. The aldosterone promotional effect on hepatic fibrosis was partially mediated by TGF-β1.

[Interleukin-10 Inhibits the Activation of Cultured Rat Hepatic Stellate Cells Induced by Kupffer Cells].

Antifibrotic Effects of Interleukin-10 on Experimental Hepatic Fibrosis.

[Regulation of Hepatic Stellate Cell Activation by Interleukin-10/Platelet Derived Growth Factor/mitogen-Activated Protein Kinase Pathway].

[Downregulation of Transforming Growth Factor-Beta1 and Platelet-Derived Growth Factor Gene Expression by Interleukin-10 in Murine Hepatic Stellate Cells in Response to Experimental Liver Injury].

IL-10 receptor and coreceptor expression in quiescent and activated hepatic stellate cells.

Effect of Interleukin-10 and Platelet-Derived Growth Factor on Expressions of Matrix Metalloproteinases-2 and Tissue Inhibitor of Metalloproteinases-1 in Rat Fibrotic Liver and Cultured Hepatic Stellate Cells

[An in Vivo Study on Interlukin-10 Inhibiting the Expression and Secretion of Collagen I and IV in Hepatic Stellate Cells].

Effect of interleukin-10 on expression of TGF-β and PDGF by hepatic stellate cells co-cultured with KC

The Effect of AdIL-10 on the Expression of Α-Sma, TGF-β1 and TNF-α in HSC

Different Effects of Rat Interferon Alpha, Beta and Gamma on Rat Hepatic Stellate Cell Proliferation and Activation.

Targeting Transforming Growth Factor Βrii Expression Inhibits the Activation of Hepatic Stellate Cells and Reduces Collagen Synthesis

Effects of Cytokines on Carbon Tetrachloride-Induced Hepatic Fibrogenesis in Rats

Effects of CTGF on Kupffer Cells Induced Activation of Hepatic Stellate Cells

Effect of Aldosterone and Its Antagonist on the Expression of PAI-1 and TGF-β1 in Rat Hepatic Stellate Cells.

Effect of interleukin 10 gene-modified bone marrow-derived liver stem cells transplantation on hepatic inflammatory response and liver regeneration in hepatic fibrosis rats

[Effects of Tumor Necrosis Factor Alpha on the Expression of Connective Tissue Growth Factor in Hepatic Stellate Cells].

In Vitro Study on the Role and Mechanism of Interferon Α-1B in Regulating the Inhibition of Protein Kinase Cεand Cα on Fibrosis of Hepatic Stellate Cells

IL-17 and TNF-α co-operation contributes to the proinflammatory response of hepatic stellate cells

Effects of the Tyrosine Protein Kinase Inhibitor Genistein on the Proliferation, Activation of Cultured Rat Hepatic Stellate Cells.

Inhibitory Effect of Human Interferon‐beta‐1a on Activated Rat and Human Hepatic Stellate Cells

Interleukin 10 Inhibits the Rat VSMC Proliferation and Collagen Secretion Stimulated by Angiotensin II.